Demographics and pain intensity
This study included a total of 158 adolescent patients with TMD (103 women and 55 men, mean age: 15.08 ± 2.23 years). The overall women-to-men ratio among adolescents with TMD was 1.87:1. According to the duration of symptoms, TMD was categorized as acute (symptom duration < 6 months) or chronic (symptom duration ≥ 6 months). The women-to-men ratio and mean age (p > 0.05) did not differ significantly between the acute (47 women, mean age: 14.92 ± 2.27 years) and chronic (56 women, mean age: 15.23 ± 2.19 years) TMD groups. The mean treatment duration differed significantly between the acute and chronic TMD groups (8.02 ± 6.22 vs. 13.95 ± 6.79 months, p < 0.001). Furthermore, the proportion of patients with a treatment duration > 1 year was significantly higher in the chronic TMD group than in the acute TMD group (68.7% vs. 22.7%, p < 0.001). The visual analog scale scores (VAS) recorded at the initial visit (VAS-I) and at the final visit when the treatment was completed (VAS-F) did not differ significantly between the groups (3.35 ± 2.12 vs. 2.89 ± 2.19, p = 0.188 and 0.43 ± 0.70 vs. 0.41 ± 0.83, p = 0.189) (Table 1).
Table 1
Demographics and clinical characteristics of adolescent patients with TMD
| Acute TMD (n = 75) | Chronic TMD (n = 83) | p-value |
| mean ± SD or n (%) | mean ± SD or n (%) |
Age (years) | 14.92 ± 2.27 | 15.23 ± 2.19 | 0.386 |
Sex | | | |
Male | 28 (37.3%) | 27 (32.5%) | 0.616 |
Female | 47 (62.7%) | 56 (67.5%) |
Treatment duration (months) | 8.02 ± 6.22 | 13.95 ± 6.79 | < 0.001*** |
Treatment duration ≥ 1 year (months) | 17 (22.7%) | 57 (68.7%) | < 0.001*** |
VAS-I | 3.35 ± 2.122 | 2.89 ± 2.19 | 0.188 |
VAS-F | 0.43 ± 0.70 | 0.41 ± 0.83 | 0.189 |
A t-test was used to compare the mean values between the acute and chronic TMD groups, and the chi-square test with Bonferroni correction was used to compare the distribution of n (%). Statistical significance was set at p < 0.05. ***p < 0.001 |
Acute TMD: cases in which TMD symptoms persisted for < 6 months; Chronic TMD: cases where TMD symptoms persisted for ≥ 6 months |
TMD, temporomandibular disorder; SD, standard deviation; VAS, visual analog scale; VAS-I, VAS score recorded at the initial visit; VAS-F, VAS score recorded at the final visit |
Chief complaints and factors contributing to TMD
The chief complaints included TMJ noise, pain, muscle stiffness, locking, bruxism, and uncomfortable occlusion. TMJ noise was the most common chief complaint and was significantly more prevalent in the chronic TMD group than in the acute TMD group (61.3% vs. 79.5%, p = 0.014). Pain was the most common chief complaint in the acute TMD group; however, the prevalence did not differ significantly between groups (80.0% vs. 73.5%, p = 0.354). Bruxism differed significantly between the acute and chronic TMD groups (20% vs. 39.8%, p = 0.026). Uncomfortable occlusion was significantly more common in the chronic TMD group than in the acute TMD group (20.0% vs. 38.6%, p = 0.014). Muscle stiffness (49.3% vs. 42.2%) and locking (60.0% vs. 62.7%) did not differ significantly between the acute and chronic TMD groups (p > 0.05).
Factors contributing to TMD include tinnitus, psychological stress, sleep problems, headache, orthodontic treatment, bad posture, and irregular diet. Among these factors, bad posture was most commonly observed in both groups, with a significantly higher prevalence in the chronic TMD group than in the acute TMD group (34.7% vs. 54.2%, p = 0.016). More than half of the patients with chronic TMD reported having bad posture. Sleep problems (10.7% vs. 26.5%, p = 0.014), headache (12.0% vs. 25.3%, p = 0.042), and irregular diet (12.0% vs. 30.1%, p = 0.007) were also significantly more prevalent in patients with chronic TMD than in those with acute TMD (all p < 0.05). The prevalence of tinnitus (17.3% vs. 22.9%) and psychological stress (30.7% vs. 33.7%) were higher in the chronic TMD group than in the acute TMD group, whereas orthodontic treatment (32.0% vs. 21.7%) was less prevalent in the chronic TMD group; however, none of these differences were statistically significant (all p > 0.05) (Table 2).
Table 2
Clinical characteristics of acute and chronic TMD
| Acute TMD (n = 75) | Chronic TMD (n = 83) | p-value |
| mean ± SD or n (%) | mean ± SD or n (%) |
Chief complaints | | | |
TMJ noise | 46 (61.3%) | 66 (79.5%) | 0.014* |
TMD pain | 60 (80.0%) | 61 (73.5%) | 0.354 |
Muscle stiffness | 37 (49.3%) | 35 (42.2%) | 0.425 |
Locking | 45 (60.0%) | 52 (62.7%) | 0.746 |
Bruxism | 17 (22.7%) | 33 (39.8%) | 0.026* |
Uncomfortable occlusion | 15 (20.0%) | 32 (38.6%) | 0.014* |
Contributing factors | | | |
Tinnitus | 13 (17.3%) | 19 (22.9%) | 0.432 |
Psychological stress | 23 (30.7%) | 28 (33.7%) | 0.735 |
Sleep problem | 8 (10.7%) | 22 (26.5%) | 0.014* |
Headache | 9 (12.0%) | 21 (25.3%) | 0.042* |
Orthodontic treatment | 24 (32.0%) | 18 (21.7%) | 0.154 |
Bad posture | 26 (34.7%) | 45 (54.2%) | 0.016* |
Irregular diet | 9 (12.0%) | 25 (30.1%) | 0.007** |
The t-test was used to compare mean values between the adolescent TMD groups, while the chi-square test with Bonferroni correction was used to compare the distribution of n (%). Statistical significance was set at p < 0.05. *p < 0.05, **p < 0.01 |
Acute TMD: cases in which TMD symptoms persisted for < 6 months; Chronic TMD: cases in which TMD symptoms persisted for ≥ 6 months |
TMD, temporomandibular disorder; SD, standard deviation; TMJ, temporomandibular joint |
Statistical significance was set at p < 0.05. *p < 0.05, **p < 0.01, ***p < 0.001 |
PR findings
On PR, the anterior joint space was significantly smaller in patients with chronic TMD compared with that of those with acute TMD (2.41 ± 0.67 vs. 1.83 ± 0.64 mm, p < 0.001). Similarly, the posterior joint space was also significantly smaller in patients with chronic TMD compared with that of patients with acute TMD (2.48 ± 0.73 vs. 2.19 ± 0.69 mm, p = 0.012). Thus, both the anterior and posterior joint spaces were significantly reduced when TMD symptoms persisted for > 6 months. Anterior joint space narrowing was significantly more frequent in patients with chronic TMD than in those with acute TMD (30.7% vs. 58.6%, p = 0.001). Posterior joint space narrowing was observed in > 70% of both the acute (77.3%) and chronic (72.3%) TMD groups, with no significant difference between the groups (p = 0.583).
The amount of nasomaxillary (Na-Mx) discrepancy was significantly greater in the chronic TMD group than in the acute TMD group (1.06 ± 1.11 vs. 1.41 ± 1.06 mm, p = 0.045). Similarly, the amount of maxillomandibular (Mx-Mn) discrepancy was significantly greater in the chronic TMD group than in the acute TMD group (0.63 ± 1.04 vs. 0.98 ± 1.10 mm, p = 0.042). Na-Mx discrepancy was more frequently observed in the chronic TMD group than in the acute TMD group (53.3% vs. 71.1%, p = 0.032). Likewise, Mx-Mn discrepancy was more commonly observed in chronic TMD than in acute TMD groups (26.7% vs. 50.6%, p = 0.003). Therefore, when the TMD symptom duration is > 6 months, the likelihood of facial asymmetry, specifically midline discrepancies involving the nasal bone, maxilla, and mandible, increases compared with that when the TMD symptom duration is < 6 months. However, the prevalence of TMJ-OA on PR did not differ significantly between the acute and chronic TMD groups (29.3% vs. 24.1%, p = 0.476) (Table 3).
Table 3
Comparison of PR and MRI findings between groups
| Acute TMD (n = 75) | Chronic TMD (n = 83) | p-value |
| mean ± SD or n (%) | mean ± SD or n (%) |
PR | | | |
Anterior joint space | 2.41 ± 0.67 | 1.83 ± 0.64 | < 0.001*** |
Posterior joint space | 2.48 ± 0.73 | 2.19 ± 0.69 | 0.012* |
Anterior joint space narrowing | 23 (30.7%) | 47 (58.6%) | 0.001** |
Posterior joint space narrowing | 58 (77.3%) | 60 (72.3%) | 0.583 |
Na-Mx discrepancy amount | 1.06 ± 1.11 | 1.41 ± 1.06 | 0.045* |
Mx-Mn discrepancy amount | 0.63 ± 1.04 | 0.98 ± 1.10 | 0.042* |
Na-Mx discrepancy | 40 (53.3%) | 59 (71.1%) | 0.032* |
Mx-Mn discrepancy | 20 (26.7%) | 42 (50.6%) | 0.003** |
TMJ OA_PR | 22 (29.3%) | 20 (24.1%) | 0.476 |
MRI |
TMJ-OA_MRI | 40 (53.3%) | 47 (56.6%) | 0.749 |
ADD_MRI | 51 (68.0%) | 72 (86.7%) | 0.007** |
The t-test was used to compare mean values between the adolescent TMD groups, while the chi-square test with Bonferroni correction was used to compare the distribution of n (%). Statistical significance was set at p < 0.05. *p < 0.05, **p < 0.01, ***p < 0.001 |
Acute TMD: cases in which TMD symptoms persisted for < 6 months; Chronic TMD: cases in which TMD symptoms persisted for ≥ 6 months |
TMD, temporomandibular disorder; SD, standard deviation; Na-Mx discrepancy, nasomaxillary midline discrepancy; Mx-Mn discrepancy, maxillomandibular midline discrepancy; TMJ, temporomandibular joint; OA, osteoarthritis; PR, panoramic radiography; MRI, magnetic resonance imaging; ADD, anterior disc displacement |
MRI findings of acute and chronic TMD
Evaluation of the most common factors observed on MRI, TMJ-OA, and anterior disc displacement (ADD) revealed that TMJ-OA occurred more frequently on MRI than on PR, with > 50% of patients in both groups having this condition. The prevalence of TMJ-OA on MRI did not significantly between patients with acute and chronic TMD (53.3% vs. 56.6%, p = 0.749). In contrast, ADD on MRI was significantly more prevalent in patients with chronic TMD than in those with acute TMD (68.0% vs. 86.7%; p = 0.007). Cramer's V analysis showed that the presence of TMJ-OA on MRI was significantly associated with the presence of ADD on MRI (r = 0.233, p = 0.005) and decreased anterior joint space narrowing on PR (r = 0.117, p = 0.026). In contrast, TMJ-OA on PR was not significantly associated with anterior joint space narrowing (Table 3).
Correlations with TMD symptom duration
The results of Spearman's correlation analysis revealed the strong positive association between symptom and treatment durations (r = 0.42, p < 0.001), indicating that increased symptom duration was significantly associated with increased treatment duration. Symptom duration was also negatively correlated with anterior joint space (r=-0.30, p < 0.001), suggesting that a longer symptom duration was associated with decreased anterior joint space. Additionally, symptom duration was positively correlated with Na-Mx discrepancy (r = 0.23, p = 0.003) (Fig. 2). VAS-I and VAS-F were positively correlated, in which a higher VAS-I score was associated with a higher VAS-F score (r = 0.31, p < 0.001). However, VAS-I and VAS-F were not significantly correlated with Na-Mx or Mx-Mn discrepancies.
Considering the multiple relationships among symptom duration, treatment duration, anterior joint space, and skeletal discrepancy, increased Na-Mx discrepancy was significantly associated with both increased symptom duration and decreased anterior joint space (all p < 0.05) (Fig. 3A). The pattern of associations for Mx-Mn discrepancy with the other variables was similar to that observed for Na-Mx discrepancy; however, these relationships were not statistically significant (all p > 0.05) (Fig. 3B).
2D and 3D visualization of the relationships between chronic TMD and other factors
The factors significantly associated with the occurrence of chronic TMD (Euclidean distance ≤ 0.2), ranked in the order of proximity and strength of association with chronic TMD, were treatment duration, anterior and posterior joint spaces, ADD on MRI, poor body posture, TMJ noise, and sleep problems (Fig. 4A). This relationship diagram only represents the degree of association with chronic TMD and does not indicate positive or negative correlations. The factors more strongly associated with the development of chronic TMD than with development of acute TMD were longer or prolonged treatment duration, reduced anterior and posterior joint spaces, ADD on MRI, poor body posture, TMJ noise, and sleep problems. These factors showed complex interrelationships (Fig. 4B). Additionally, although previous studies have suggested that women are more susceptible to chronic pain than men 31,32, the present study observed no significant correlation between sex and chronic TMD in adolescent patients with TMD. While no consistent consensus has been reached regarding the relationship between orthodontic treatment during adolescence and TMD development 33,34, the present study observed no significant association between orthodontic treatment and TMD chronicity.
Logistic regression analysis of chronic TMD
Logistic regression analysis using both crude and adjusted models controlling for age and sex to identify the predictors of chronic TMD compared with those of acute TMD revealed that the factors associated with chronic TMD included treatment duration ≥ 1 year, anterior joint space narrowing, ADD on MRI, Na-Mx discrepancy, and bruxism. In the crude model, treatment duration > 1 year showed the strongest association with chronic TMD (odds ratio [OR]: 8.145, 95% confidence interval [CI]: 3.201–20.727, p < 0.001). The next strongest predictor was anterior joint space narrowing (OR: 6.060, 95%CI: 2.223–16.524, p < 0.001), followed by ADD on MRI (OR: 5.115, 95%CI: 1.632–16.037, p = 0.005), Na-Mx discrepancy (OR: 4.708, 95%CI: 1.630–13.595, p = 0.004), and bruxism (OR: 4.625, 95%CI: 1.579–13.548, p = 0.005). In the adjusted model, treatment duration > 1 year also showed the strongest association with chronic TMD (OR: 8.643, 95%CI: 3.285–22.738, p < 0.001). The next strongest predictor was anterior joint space narrowing (OR: 7.225, 95%CI: 2.550–20.470, p < 0.001), followed by ADD on MRI (OR: 5.448, 95%CI: 1.681–17.651, p = 0.005), Na-Mx discrepancy (OR: 5.119, 95%CI: 1.720–15.233, p = 0.003), and bruxism (OR: 4.702, 95%CI: 1.595–13.865, p = 0.005) (Table 4).
Table 4
Results of the logistic regression analysis to predict chronic TMD
| Crude model | | | Adjusted model | | |
Parameter | OR | Wald 95% CI_Lower | Wald 95% CI_Upper | p-value | OR | Wald 95% CI_Lower | Wald 95% CI_Upper | p-value |
TMJ noise | 1.637 | 0.595 | 4.499 | 0.340 | 1.635 | 0.574 | 4.657 | 0.358 |
Bruxism | 4.625 | 1.579 | 13.548 | 0.005* | 4.702 | 1.595 | 13.865 | .005** |
Uncomfortable occlusion | 1.167 | 0.413 | 3.300 | 0.771 | 1.301 | 0.453 | 3.739 | 0.625 |
Sleep problem | 1.480 | 0.438 | 5.005 | 0.528 | 1.361 | 0.392 | 4.721 | 0.627 |
Headache | 1.888 | 0.534 | 6.680 | 0.324 | 1.870 | 0.522 | 6.703 | 0.337 |
Bad posture | 2.333 | 0.883 | 6.162 | 0.087 | 2.236 | 0.827 | 6.047 | 0.113 |
Irregular diet | 2.531 | 0.731 | 8.764 | 0.143 | 2.711 | 0.789 | 9.313 | 0.113 |
Anterior joint space narrowing | 6.060 | 2.223 | 16.524 | < 0.001*** | 7.225 | 2.550 | 20.470 | < 0.001*** |
Posterior joint space narrowing | 0.396 | 0.137 | 1.146 | 0.088 | 0.433 | 0.144 | 1.307 | 0.138 |
Na-Mx discrepancy | 4.708 | 1.630 | 13.595 | 0.004** | 5.119 | 1.720 | 15.233 | 0.003** |
Mx-Mn discrepancy | 1.742 | 0.658 | 4.615 | 0.264 | 1.840 | 0.673 | 5.031 | 0.235 |
ADD on MRI | 5.115 | 1.632 | 16.037 | 0.005** | 5.448 | 1.681 | 17.651 | 0.005** |
Treatment duration ≥ 1 year | 8.145 | 3.201 | 20.727 | < 0.001*** | 8.643 | 3.285 | 22.738 | < 0.001*** |
Constant | 0.009 | | | 0.000 | 0.000 | | | 0.000 |
The results were obtained using multiple logistic regression analysis. TMD, temporomandibular disorder; TMJ, temporomandibular joint; OR, odds ratio; CI, confidence interval; Na-Mx, nasomaxillary midline discrepancy; Mx-Mn, maxillomandibular midline discrepancy; ADD, anterior disc displacement; MRI, magnetic resonance imaging |
Statistical significance was set at p < 0.05. *p < 0.05, **p < 0.01, ***p < 0.001 |